2019 Dallas Meeting Masthead

Industry-Supported Events

The American Society of Breast Surgeons is pleased to offer the opportunity for industry-supported symposia at its annual meeting. Symposia are live educational programs sponsored and funded by an outside organization, independently organized and offered. Industry-supported symposia, which have been made possible through marketing support, will be offered on Wednesday, Thursday and Friday evening, as well as Saturday morning during the meeting. Details on these programs are listed below, including how to register and who to contact for more information. This information will be updated as we receive additional programming details.

Note: Satellite Symposia are supported by specific companies and are supported through a marketing grant. They are not part of the official program of the ASBrS and are free to all registered attendees.


Wednesday Evening Symposia

Ambry Genetics, Inc.

May 1, 8:00 PM–9:30 PM, Location: Monet

Sharpen your Skills: Hot Topics in Genetic Testing for Hereditary Breast Cancer
Presenter:
  • Katharine A. Yao, MD, NorthShore Medical Group

Join us for dinner to learn more about hot topics in genetic testing for hereditary breast cancer. As the field of hereditary cancer expands, genetic testing continues to become more important for personalized patient care. This symposium will give you answers to some of the most commonly asked questions from breast surgeons. We will discuss the role of breast surgeons in genetic testing, how to handle variants of unknown significance, contralateral breast cancer risk for both high and moderate risk genes, and the difference between direct-to-consumer testing and clinical genetic testing.

To register, click here: Wednesday 5/1 Night Dinner Symposium

For more information, visit www.ambrygenetics.com or contact Zach Jensen at zjensen@ambrygenetics.com.

Note: This satellite symposium is supported by Ambry Genetics, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


GE Healthcare

May 1, 8:00 PM–9:30 PM, Location: Metropolitan

Contrast Enhanced Mammography: A Simplified Way to Address the Advanced Imaging Needs of Your Patients

Meet the needs for neoadjuvant treatment, post-surgery surveillance and others. Learn from a breast surgeon about CESM and how she uses it in practice. Overview and cases will be shared.

Presenter:
  • Juliann M. Reiland, MD, Avera Medical Group, Sioux Falls, SD

To register, click HERE.

For more information, contact Sandie Sands at Stacie.sands@ge.com.

Note: This satellite symposium is supported by GE Healthcare, through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Thursday Evening Symposium

Genomic Health, Inc.

May 2, 5:30 PM–7:30 PM, Location: Trinity Ballroom

Beyond TAILORx: Using Recurrence Score® Results in Loco-Regional Control, Node-Positive and Neoadjuvant Decisions
Presenters:
  • Richard J. Bleicher, MD, FACS, Professor, Department of Surgical Oncology, Director, Breast Fellowship Program, Fox Chase Cancer Center
  • Terry Mamounas, MD, MPH, Medical Director, Comprehensive Breast Program, Orlando Health, UF Health Cancer Center
  • Tari A. King, MD, FACS, Chief of Breast Surgery, Dana Farber/Brigham and Women’s Cancer Center, Associate Professor of Surgery, Harvard Medical School
  • Christy A. Russell, MD, Senior Director, Medical Affairs, Genomic Health

To register for this activity, click here: Register

Note: This satellite symposium is supported by Genomic Health, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees


Friday Evening Symposia

Genentech

May 3, 7:30 pm–9:30 pm, Location: Chantilly Ballroom West

Treatment Considerations for High Risk Patients with Early Breast Cancer

How to Register: www.geniersvp.com/SGEN22984

For more information, contact Erin Hays at EHays@medforce.net.

Note: This satellite symposium is supported by Genentech, through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Stryker

May 3, 7:30 PM–9:30 PM, Wedgwood Ballroom

Breast Cancer Surgery Redefined: Novel Technologies and Techniques that Expand Indications for Nipple Sparing Mastectomy, Oncoplastic Surgery and Hidden Scar® Techniques

This symposium will discuss the advanced techniques, considerations and enabling technologies for Nipple Sparing Mastectomy, Oncoplastic surgery and Hidden Scar Techniques. With the emphasis on both the oncologic and psychosocial outcomes of breast cancer treatment, the keynote speakers will address how to expand indications for optimal techniques that prioritize survivorship.

To register, click HERE.

For more information, contact Hannah LaBomascus at Hannah.labomascus@stryker.com.

Note: This satellite symposium is supported by Stryker, through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Saturday Breakfast Symposia

Albert Einstein College of Medicine

May 4, 6:30 AM–7:45 AM, Coronado A Ballroom

Virtual Cadaver Hands-On Workshop: Identifying Breast and Abdominal Planes for Surgical Infiltration to Manage Post-Surgical Pain
Program Objective:
  • Describe the opioid epidemic and associated adverse events with opioids
  • Review the multimodal options utilized pre-op, inter-op and post-op in breast reconstruction surgery
  • Identify the surgical anatomy targeting PECS I, II, III, serratus, classic tap, subcostal and rectus sheath blocks
  • Demonstrate skill in ultrasound guided interscalene brachial plexus block and specific fascial plane block techniques via hands-on practice on live models, phantom stations

The symposium will include a faculty presentation, questions and answers and a hands-on workshop. It will provide the learners with the opportunity to participate in the hands-on scanning portion of the works and interact with faculty in real time.

How to Register: Please click on the following link: www.eeds.com/live/300654.

For more information, contact Stacy Atkinson, MS, CM, at 718-920-6674, or statkins@montefiore.org.

Note: This satellite symposium is supported by Pacira Pharmaceuticals through an educational grant provided to Albert Einstein College of Medicine. CME credits for this program will be provided by Albert Einstein College of Medicine. It is not part of the official program of the ASBrS*. This activity is free to all registered attendees. (*An independent grant from Albert Einstein College of Medicine was provided to the ASBrS in order to offer this satellite symposium during the 20th Annual Meeting.)


Cianna Medical, Inc., Powered by Merit Medical

May 4, 6:30 AM–7:45 AM, Wedgwood Ballroom

Advanced Utilization of Wire-Free Technology from Biopsy to Surgery

Learn how advanced applications of SCOUT® Radar Localization enable enhanced efficiency, precision and patient experience for placement at time of biopsy, localization prior to neoadjuvant therapy, and oncoplastic surgery.

Who Should Attend:
  • This THINK Wire-Free™ event is designed for surgeons, breast surgery fellows and administrators interested in learning more about advanced applications of wire-free tumor localization.
Presenters:
  • Barry Rosen, MD, Medical Director, Breast Center at Advocate Good Shepherd Hospital, Barrington, IL
  • Anne Peled, MD, Co-Director of the Sutter Health California Pacific Medical Center Breast Cancer Center of Excellence, San Francisco, CA

To register: www.merit.com/thinkwirefree

This Ancillary Event is an educational activity and is not approved for CME or continuing education credit. The content of this Ancillary Event and opinions expressed by presenters are those of the sponsors or presenters.

Note: This satellite symposium is supported by Cianna Medical, Inc., Powered by Merit Medical, through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Hologic, Inc.

May 4, 6:30 AM–7:45 AM, Chantilly Ballroom West

BioZorb® and a New Way to 5-day
Presenter:
  • Valerie Gorman, MD, FACS
    Breast Surgeon
    Baylor Scott & White Texas Surgical Specialists
    Waxahachie, TX

There is no pre-registration and access to the symposium will be first come, first serve with a breakfast buffet available in the room. Seating is strictly limited to 50 attendees.

Contact MedEd-BSH@hologic.com for questions regarding the breakfast symposium. For additional education opportunities, visit HologicED.com.

Note: This satellite symposium is supported by Hologic, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


PeerView Institute

May 4, 6:30 AM–7:45 AM, Coronado B, C, D

On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Program Objective:
After participating in the activity, the learners are expected to be better able to:
  1. Describe the biologic rationale and rational strategies for harnessing the immune system in the treatment of triple-negative breast cancer (TNBC) specifically, and in breast cancer more broadly, including combinatorial or sequential approaches with immune checkpoint inhibitors and other effective therapies (eg, chemotherapies, other immunotherapies, PARP inhibitors and other targeted agents, surgery, radiation, etc.) that may enhance immunogenicity and improve outcomes
  2. Discuss biomarkers that may have utility in guiding and refining clinical decisions regarding the selection of appropriate candidates for immune-based and other therapies in TNBC, and the nuances of testing for these biomarkers in practice
  3. Analyze efficacy, safety, and other key data from clinical trials assessing immunotherapy and immune-based combinations or sequential strategies with other effective treatment modalities throughout the continuum of TNBC, including metastatic, locally advanced, and early-stage resectable disease
  4. Integrate immune checkpoint inhibitors and/or other effective treatment modalities into management plans of patients with TNBC based on the latest evidence, indications, recommendations, disease stage, patient and tumor characteristics, biomarker testing results, and patient needs/preferences
Program Description:

Tremendous advances have been made in the treatment of many other subtypes of breast cancer, but treatment of triple-negative breast cancer (TNBC) has remained challenging. However, recent developments suggest that we are on the brink of a new era in TNBC therapy that now brings the novel class of cancer immunotherapies to this population of patients. What is the most rational way and optimal setting to use of cancer immunotherapies? How can we maximize their benefits so that more patients with TNBC would benefit from them?

In this CME/MOC/CNE-accredited PeerView MasterClass symposium, our expert panel discusses the biologic rationale for the use of cancer immunotherapies in breast cancer in general and TNBC specifically, as well as evolving evidence supporting the use of immune checkpoint inhibitors in advanced/metastatic and early-stage resectable TNBC (including clinical trials focused on monotherapy approaches, combinatorial approaches with different chemotherapies, and combination or sequential strategies with targeted agents, different immunotherapies, vaccines, radiation, surgery, and other treatment modalities). Additionally, the panel will focus on patient/tumor evaluation and candidate selection for immunotherapy, using current and novel biomarkers to guide clinical decisions in early-stage and advanced disease, the importance of being aware of potential immune-related adverse events and how to diagnose/manage them, and the need for close collaboration among breast surgeons, oncologists, pathologists, and other professionals involved in the management of patients with breast cancer. Illustrative case studies and clinical scenarios during the Practicum segment will provide further guidance on strategies for educating patients and best practices for the use and integration of immunotherapies into the treatment arsenal for patients with TNBC in real-world, clinical practice settings.

Chair:
  • Elizabeth A. Mittendorf, MD, PhD
    Brigham and Women’s Hospital
    Dana-Farber/Brigham and Women’s Cancer Center
    Boston, Massachusetts
  • Heather L. McArthur, MD, MPH
    Samuel Oschin Comprehensive Cancer Center
    Cedars-Sinai Medical Center
    Los Angeles, California
  • Jennifer Litton, MD
    The University of Texas MD Anderson Cancer Center
    Houston, Texas

How to Register: www.PeerView.com/TNBCresect

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. This activity is supported by an independent educational grant from Merck & Co., Inc.

Note: This satellite symposium is supported by Merck & Co., Inc. through an independent educational grant provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. CME credits for this program will be provided by Medical Learning Institute, Inc. It is not part of the official program of the ASBrS*. This activity is free to all registered attendees. (*An independent grant from Medical Learning Institute, Inc. was provided to the ASBrS in order to offer this satellite symposium during the 20th Annual Meeting.)


Other Special Events

Our Special Events page has even more Annual Meeting events held throughout the General Session.